Find clinical trials for Lung Cancer in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Pittsburgh, PA, USA:
and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer...
Phase 2
Pittsburgh, Pennsylvania, United States and 64 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Natrona Heights, Pennsylvania, United States and 43 other locations
This phase II clinical trial will study the safety and efficacy of onvansertib to treat patients with small cell lung cancer (SCLC)...
Phase 2
Pittsburgh, Pennsylvania, United States and 1 other location
The main aim of this study is to:evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1] by investiga...
Phase 2
Pittsburgh, Pennsylvania, United States and 79 other locations
, early-stage non-small cell lung cancer....
Phase 2
Pittsburgh, Pennsylvania, United States and 94 other locations
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who progressed on First-Line Osimertinib Therapy. This study...
Phase 2
Pittsburgh, Pennsylvania, United States and 46 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Pittsburgh, Pennsylvania, United States and 157 other locations
overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...
Phase 2
Pittsburgh, Pennsylvania, United States and 126 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Pittsburgh, Pennsylvania, United States and 181 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Pittsburgh, Pennsylvania, United States and 230 other locations
Clinical trials
Research sites
Resources
Legal